The National Institutes of General Medical Sciences has set aside $3 million in fiscal year 2013 to fund the development of new experimental and computational approaches to determine the functional relevance of human DNA sequence variants.

According to a recent funding opportunity announcement, NIGMS is seeking applications that use biochemical, cellular, bioinformatic, statistical, or high-throughput methods to interpret DNA sequence variation in a well-phenotyped population. Proposed studies should use existing DNA sequence and phenotype data.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.